Company intelligence / Profile preview

Stimuli Technology

Boulogne-Billancourt, Île-de-France, Francetensiplus.com ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Stimuli Technology has developed Tensi+, a medical device using neurostimulation via transcutaneous electrical nerve stimulation to treat symptoms of overactive bladder. The company is focused on providing non-invasive solutions for urinary disorders, particularly targeting patients with hyperactive bladders. Clinical results or trial data are not detailed in the available sources, but the product is described as developed and marketed.

Therapeutic areas: NephrologyUrology
Modalities: DeviceNeurostimulation deviceTranscutaneous electrical nerve stimulation (TENS) device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Stimuli Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stimuli Technology.

Explore the full profile